These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5086130)

  • 41. [Rate of aging of acetylcholinesterase and butyrylcholine esterase inhibited by O-isopropyl-S-(2-diisopropylaminoethyl)-methylthiophosphonate].
    Patocka J; Bajgar J
    Cesk Farm; 1974 Feb; 23(1):25-7. PubMed ID: 4458970
    [No Abstract]   [Full Text] [Related]  

  • 42. [Microelectrophoretic study of the choline sensitivity of amygdaloid complex neurons].
    Gilinskii MA; Vol'f NV
    Neirofiziologiia; 1972; 4(6):645-50. PubMed ID: 4658546
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anticholinesterase activity and toxicity of substituted O,O-dialkyl-S-vinyl phosphates and thiovinyl phosphonium salts].
    Pesotskaia GV; Petrenko VS; Panasiuk AI; Danchenko MN; Kasukhin LF; Gololobov IuG
    Ukr Biokhim Zh (1978); 1981; 53(4):35-41. PubMed ID: 7281252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Acetylcholine and lipolytic activity of brain tissue].
    Demin NN; Rubinskaia NL
    Biull Eksp Biol Med; 1966 Sep; 62(9):51-3. PubMed ID: 6012422
    [No Abstract]   [Full Text] [Related]  

  • 45. Methamidophos: an anticholinesterase without significant effects on postsynaptic receptors or transmitter release.
    Camara AL; Braga MF; Rocha ES; Santos MD; Cortes WS; Cintra WM; Aracava Y; Maelicke A; Albuguergue EX
    Neurotoxicology; 1997; 18(2):589-602. PubMed ID: 9291508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons.
    Darvesh S; Arora RC; Martin E; Magee D; Hopkins DA; Armour JA
    Exp Neurol; 2004 Aug; 188(2):461-70. PubMed ID: 15246845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of topically applied cholinomimetic drugs on the isolated spinal cord of the toad.
    Phillis JW; Tebĕcis AK
    Comp Biochem Physiol; 1967 Nov; 23(2):541-52. PubMed ID: 6080512
    [No Abstract]   [Full Text] [Related]  

  • 48. [Nucleic acids of the neuron-neuroglia system in anterior horns of spinal cord and in cerebellum under the action of anticholinesterase agents].
    Rubinskaia NL
    Biokhimiia; 1968; 33(4):726-32. PubMed ID: 5727720
    [No Abstract]   [Full Text] [Related]  

  • 49. [The causes of low activity of various cholinomimetics in experiments on isolated molluskan neurons].
    Skliarov AI; Lavrent'eva VV
    Dokl Akad Nauk SSSR; 1988; 300(1):245-8. PubMed ID: 2458217
    [No Abstract]   [Full Text] [Related]  

  • 50. Protective effect of pretreatment against the anticholinesterase action of cyanofenphos.
    Konno N; Yamauchi T; Yamaguchi Y; Fukushima M
    Dev Toxicol Environ Sci; 1983; 11():503-6. PubMed ID: 6677495
    [No Abstract]   [Full Text] [Related]  

  • 51. Cholinesterase activity in ganglia of gastropoda, Lymnaea stagnalis and planorbarius corneus. II. Histochemical investigation.
    Jurchenko OP; Kultas KN; Vulfius CA
    Comp Biochem Physiol A Comp Physiol; 1973 May; 45(1):61-8. PubMed ID: 4145711
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparison of some stereochemical requirements of the acetylcholinesterase and muscarinic receptor areas.
    Cocolas GH; Robinson EC; Dewey WL
    J Med Chem; 1970 Mar; 13(2):299-301. PubMed ID: 5418506
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of sublethal doses of cholinesterase inhibitors on spontaneous motor activity in laboratory rats.
    Koupilová M; Herink J; Bajgar J
    Homeost Health Dis; 1991; 33(5-6):299-300. PubMed ID: 18265508
    [No Abstract]   [Full Text] [Related]  

  • 54. Ionic secretion by epithelial membranes.
    Slegers JF
    Ciba Found Study Group; 1968; 32():68-89. PubMed ID: 5760788
    [No Abstract]   [Full Text] [Related]  

  • 55. Achievements in cholinergic research, 1969-1989: drug development.
    Jenden DJ
    Prog Brain Res; 1990; 84():479-86. PubMed ID: 2267317
    [No Abstract]   [Full Text] [Related]  

  • 56. Inhibition of acetylcholinesterase in the brain and diaphragm of rats by a tertiary organophosphorous anticholinesterase and its quaternary analogue; in vivo and in vitro studies.
    Lancaster R
    J Neurochem; 1972 Nov; 19(11):2587-97. PubMed ID: 5086246
    [No Abstract]   [Full Text] [Related]  

  • 57. [Direct effect of VX and soman on nicotinic receptors].
    Chen SM; Chi MG
    Zhongguo Yao Li Xue Bao; 1986 Sep; 7(5):401-6. PubMed ID: 2954410
    [No Abstract]   [Full Text] [Related]  

  • 58. Investigations, particularly by means of the anticholinesterase agents, of the multiple peripheral and central cholinergic mechanisms and of their behavioral implications.
    Karczmar AG; Ishi S; Blaber LC
    Acta Vitaminol Enzymol; 1970; 24(4):131-89. PubMed ID: 5537191
    [No Abstract]   [Full Text] [Related]  

  • 59. Carboxylesterase inhibition as an indicator of malathion potentiation in mice.
    Cohen SD; Murphy SD
    J Pharmacol Exp Ther; 1971 Mar; 176(3):733-42. PubMed ID: 5111459
    [No Abstract]   [Full Text] [Related]  

  • 60. Excitatory actions of acetylcholine in the heart.
    Burn JH
    Br J Pharmacol; 1979 Sep; 67(1):3-12. PubMed ID: 497520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.